Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Sarcoma 1CNS 1

Conditions

Brain Neoplasms 15Glioblastoma 9Carcinoma, Non-Small-Cell Lung 9Gliosarcoma 7Central Nervous System Neoplasms 4Lung Neoplasms 3Oligodendroglioma 2Neuroblastoma 2Neoplasms 2Glioma 2Astrocytoma 2Untreated Childhood Anaplastic Astrocytoma 1Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Parathyroid Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Meningioma 1Glioma, Subependymal 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Radiotherapy 5Magnetic Resonance Spectroscopy 5Docetaxel 5Specimen Handling 4Gemcitabine 3Cyclophosphamide 3temsirolimus 2fludarabine 2Trastuzumab 2Temozolomide 2Sirolimus 2Radiosurgery 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Leucovorin 2Injections 2Fluorouracil 2Fluorodeoxyglucose F18 2Blood Specimen Collection 2Biopsy 2Bevacizumab 2Azacitidine 2vandetanib 1ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Gefitinib × CNS × Clear all
NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
61 enrolled 8 charts
CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡